JASPER THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.99 USD | +0.50% |
|
+8.90% | +204.06% |
Chart calendar Jasper Therapeutics, Inc.
5e2a7146f390c8284b7d8b7.9g7npFvhpZk7KbvqLFPa4TsVIhAZkqqt610dFjR6Tzg.mGnTyw24w898Rey9XSq1jnpQdmQh3JL-tDN7IEcrKmu7a4iXC9aX80Nx3A~6503c2ddd7206d742d58f09ec89b5f32
Upcoming events on Jasper Therapeutics, Inc.
Past events on Jasper Therapeutics, Inc.
| 08/04/2024 16:00 | Needham Healthcare Conference |
| 28/03/2024 14:00 | H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference |
| 04/03/2024 15:30 | TD Cowen Health Care Conference |
| 04/03/2024 12:30 | Q4 2023 Earnings Release |
| 25/02/2024 21:45 | American Academy of Allergy, Asthma & Immunology Meeting |
| 24/02/2024 19:00 | American Academy of Allergy, Asthma & Immunology Meeting |
| 23/02/2024 20:15 | American Academy of Allergy, Asthma & Immunology Meeting |
| 13/02/2024 21:40 | Oppenheimer Healthcare Life Sciences Conference |
| 15/12/2023 18:00 | Extraordinary Shareholders Meeting |
| 10/12/2023 17:30 | American Society of Hematology Meeting |
| 30/11/2023 19:00 | Piper Sandler Healthcare Conference |
| 29/11/2023 14:10 | Evercore ISI HealthCONx Conference |
| 15/11/2023 18:50 | Stifel Healthcare Conference |
| 10/11/2023 23:45 | American College of Allergy Asthma & Immunology Scientific Meeting - Abstract No - 8266 |
| 09/11/2023 13:00 | Q3 2023 Earnings Release |
| 11/10/2023 13:00 | Investor Meeting - Key Opinion Leader |
| 27/09/2023 | Fanconi Anemia Research Fund Scientific Symposium |
| 27/09/2023 19:25 | Cantor Global Healthcare Conference |
| 11/08/2023 21:05 | Q2 2023 Earnings Release |
| 07/06/2023 18:00 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -36,5 -35,8 -1.75% | -46,1 -48,7 5.26% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -36,8 -35,4 -4.16% | -51,2 -51,3 0.28% | -68,9 -70,4 2.24% | -75,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -30,6 -34,8 11.89% | -37,7 -38,4 1.93% | -64,5 -66,2 2.59% | -71,0 |
|
Net income Million USD | Released Forecast Spread | -31,7 | -30,6 -34,8 11.89% | -37,7 -38,4 1.93% | -64,5 -66,2 2.59% | -71,0 |
|
EPS USD | Released Forecast Spread | -51,7 | -26,9 -22,3 -20.63% | -10,3 -10,5 1.9% | -6,18 -6,34 2.45% | -4,98 |
| Announcement Date | 08/06/21 | 18/03/22 | 08/03/23 | 04/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -12,4 -11,0 -13.09% | -11,9 -12,1 1.9% | -17,6 -12,6 -39.3% | |||||||||||
|
EBIT Million USD | Released Forecast Spread | -12,1 -10,1 -19.71% | -12,8 -12,1 -5.36% | -12,0 -13,9 13.95% | -12,7 -14,0 9.01% | -13,7 -13,9 0.95% | -13,9 -13,6 -2.85% | -17,8 -16,2 -9.79% | -19,4 -17,7 -9.1% | -17,7 -19,3 8.38% | -18,2 | -18,3 | -18,7 | -19,3 | -16,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,06 -9,85 8.08% | -2,21 -13,1 83.1% | -10,4 -11,6 10.66% | -11,9 -12,8 7.01% | -13,2 -13,6 2.51% | -14,3 -14,0 -1.99% | -16,1 -15,8 -1.93% | -17,5 -17,1 -2.51% | -16,6 -18,6 11.09% | -17,2 | -17,1 | -17,7 | -18,4 | -16,1 |
|
Net income Million USD | Released Forecast Spread | -9,06 -9,85 8.08% | -2,21 -13,1 83.1% | -10,4 -11,6 10.66% | -11,9 -12,8 7.01% | -13,2 -13,6 2.51% | -14,3 -14,0 -1.99% | -16,1 -15,8 -1.93% | -17,5 -17,1 -2.51% | -16,6 -18,6 11.09% | -17,2 | -17,1 | -17,7 | -18,4 | -16,1 |
|
EPS USD | Released Forecast Spread | -2,50 -3,60 30.56% | -0,60 -3,50 82.86% | -2,90 -3,13 7.45% | -3,20 -3,40 5.88% | -3,60 -3,74 3.74% | -1,60 -1,62 1.23% | -1,50 -1,50 0% | -1,60 -1,57 -2.13% | -1,50 -1,70 11.5% | -1,18 | -1,14 | -1,16 | -1,12 | -0,83 |
| Announcement Date | 18/03/22 | 12/05/22 | 12/08/22 | 10/11/22 | 08/03/23 | 12/05/23 | 11/08/23 | 09/11/23 | 04/03/24 | - | - | - | - | - |
More events
Past sector events for Jasper Therapeutics, Inc.
| Today | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| Today | AMGEN INC.: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 01/05/2024 11:45 | PFIZER, INC.: Q1 2024 Earnings Release |
| 01/05/2024 08:00 | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 01/05/2024 07:00 | GSK PLC: Q1 2024 Earnings Release |
| 30/04/2024 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- JSPR Stock
- Calendar Jasper Therapeutics, Inc.
